coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Total Health Excellence West PCN, Folkestone and Hythe · Health Inequalities Profile

    PCN U51839 · NHS Kent and Medway Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    42,016

    Registered population

    59.9% aged 18–64

    20.5%

    Aged 65+

    ICB 19.9% · England 17.9%

    11.1%

    Ethnic minority (non-White)

    6.1% Asian · England 9.6%

    38.5%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~15,711

    Core20 residents (est.)

    Resident basis; registered basis ~16,602 · see page 3

    6,933

    Hypertension register

    +7.44% in 3 yrs · England +5.60%

    681

    SMI register

    48.2% of Folkestone and Hythe's

    1,181

    COPD register

    Reviews +17.61% in 3 yrs

    Forecast to 2030

    8,352

    Hypertension patients, 2030

    +1,419 on today

    61.3%

    QRISK ≥20% on statins, 2030

    +2.10pp over 3 yrs

    5.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.2%
    Asthma annual reviews fall behind England.

    Asthma annual reviews fell 8.3% over 2023 to 2025 to 57.2% (England 65.7%), leaving an estimated 1,155 scale on the 2,697 register.

    60.6%
    Under-80s BP control and lipid therapy lag.

    Under-80s blood pressure control is 60.6% (England 67.8%) and QRISK ≥ 20% lipid therapy is 56.9% (England 63.6%), which may reflect recall gaps.

    +17.6%
    COPD reviews and 80+ BP control improved.

    Over 2023 to 2025, COPD annual reviews rose +17.6% to 71.5% (England +2.8%) and 80+ hypertension control rose +15.0% (England +2.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older than England, the PCN includes 8,599 older patients and 35 catchment care homes

    Across 42,016 registered patients, 20.5% (8,599) are aged 65+, below Folkestone and Hythe (25.7%) but above NHS Kent and Medway ICB (19.9%) and England (17.9%). Children aged 0-17 represent 19.7% (8,272), above Folkestone and Hythe (17.4%), below the ICB (20.7%) and in line with England (19.6%). The non-White ethnic minority share is 11.1%, with Asian or Asian British residents at 6.1% (Census usual residents), above Folkestone and Hythe (3.9%) and the ICB (4.7%) but below England (9.6%). List size is projected to grow 4.3% by 2030 under an unverified methodology.

    Age profile

    0–1719.7%
    18–6459.9%
    65+20.5%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White88.9%
    Asian6.1%
    Mixed2.5%
    Other1.6%
    Black0.9%

    Older people · falls rows are Folkestone and Hythe local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Folkestone & Hythe LA)1,6992,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.1%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Folkestone & Hythe LA)8569819552024/25
    Falls deaths, all ages, per 100,000 (Folkestone & Hythe LA)16.014.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 38.5% PCN-wide and is sharply uneven between practices

    The PCN has 38.5% of registered patients living in Core20 areas (average IMD decile 3.9), well above Folkestone and Hythe (21.7%), NHS Kent and Medway ICB (17.1%) and England (21.0%). Modelled weighted practice share (39.5%) differs slightly from the PCN figure (38.5%). Deprivation is sharply uneven across a 62.5 pp practice range: Guildhall Street Surgery (65.7%, 6,547 estimated patients), The New Surgery (56.5%, 5,721) and Manor Clinic (42.0%, 3,933) heavily exceed England, while Sandgate Road records 3.2% (401). Outreach may need targeting toward high-volume practices to manage concentrated disadvantage.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Guildhall Street65.7% · 6,547 patients
    New56.5% · 5,721 patients
    Manor Clinic42.0% · 3,933 patients
    Sandgate Road3.2% · 401 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    681

    SMI register

    1.60% recorded prevalence

    416

    Learning disability register

    0.97% recorded prevalence

    35

    Care homes, 677 beds

    In the PCN catchment

    10.2%

    Provide unpaid care

    Folkestone and Hythe, Census 2021

    Recorded learning disability prevalence is 1.0% (416 patients) and severe mental illness is 1.6% (681 patients), above Folkestone and Hythe (0.9% and 1.2%), the ICB (0.6% and 0.9%) and England (0.6% and 1.0%). Catchment care homes comprise 35 sites with 677 beds, though capacity does not establish occupancy or registered resident numbers. With both registers above England and regional benchmarks, annual physical-health checks and care-home liaison may be key clinical.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.6% (England 1.0%). Annual blood pressure checks reach 78.5% (England 83.4%), with The New Surgery at 73.5% and Guildhall Street Surgery at 77.0%. PCN BMI checks reach 77.9% (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,933

    Hypertension register

    +7.44%

    Register growth, 3 yrs

    Folkestone and Hythe +5.18% · England +5.60%

    +5.67pp

    BP control, under 80

    ≤140/90 · +10.28pp aged 80+

    +1,419

    More patients by 2030

    Forecast 8,352 (18.75%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 16.2% (6,933 patients), above England (15.2%) but below Folkestone and Hythe (18.6%) and level with NHS Kent and Medway ICB (16.2%), giving an unadjusted benchmark range of -534 to +868 patients. Recent blood pressure monitoring is 83.5% (England 90.0%, NHS Kent and Medway ICB 87.3%). Blood pressure control in patients aged under 80 is 60.6% (England 67.8%, NHS Kent and Medway ICB 64.6%), with The New Surgery at 55.0%, despite PCN gains over 2023 to 2025 of +10.3% (+5.7 pp; England +3.2%, +2.1 pp). Lower control may reflect titration and recall gaps to verify locally.

    Lipids and statins

    QRISK ≥ 20% lipid-lowering therapy is 56.9% (England 63.6%, NHS Kent and Medway ICB 61.4%). In patients with diabetes aged 40+ without CVD, statin therapy is 66.7% (England 73.2%) after falling 1.3 pp over 2023 to 2025 (England +1.5 pp). Lower treatment rates may reflect initiation gaps across eligible cohorts to audit locally.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202657,638£1.90£1.90£1.86£109,512
    Cardiovascular (all), 202585,001£5.12£3.57£3.33£435,205

    In 2026, 57,638 lipid-regulating items were prescribed at £1.90 per item (England £1.86, Folkestone and Hythe £2.17, NHS Kent and Medway ICB £1.90), spending £2,306 more than at England's unit cost across 57,638 items, with no difference from NHS Kent and Medway ICB's unit cost. Adult prescribing reached 1,708 items per 1,000 (England 4,100).

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −8.34%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −4.25%

    Asthma prevalence, PCN 3-yr % change

    COPD annual reviews rose +17.6% over 2023 to 2025 to 71.5% (England 76.4%, +2.8%). Asthma reviews fell 8.3% over 2023 to 2025 (England +4.4%) to 57.2% (England 65.7%), leaving an estimated scale of 1,155 unreviewed patients on the 2,697 register. At The New Surgery, asthma reviews were 46.5%. Asthma management items prescribed per 1,000 aged 5-19 reached 1,705 (England 1,488). The drop in asthma reviews alongside elevated youth prescribing may reflect review recall gaps to audit locally.

    Cancer register and children's immunisation

    Cancer prevalence is 4.5% (1,912 patients; England 3.8%). In Q1 2025/26 age-five MMR coverage, dose 1 is 92.3% and dose 2 is 84.6%, showing a 7.7 pp dose difference, below the 95.0% target. At Guildhall Street Surgery, dose 2 is 63.2% compared with 78.9% for dose 1 (a 15.7 pp difference). The second-dose gap may reflect pre-school recall gaps to verify locally.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.0%

    England 91.0%

    6-in-1 complete primary course at 24 months94.5%

    England 92.2%

    MMR dose 1 at 24 months87.9%

    England 88.3%

    MMR dose 2 at age 584.6%

    England 82.8%

    4-in-1 pre-school booster at age 582.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In NHS Kent and Medway ICB, 55.6% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (England 55.3%), 19.4 pp below the 75.0% national ambition by 2028, requiring an estimated 1,627 extra early-stage cases annually across the ICB. Early-stage share rose 2.2 pp between 2013 and 2022, while known-stage completeness was 63.6% (8,384 of 13,189). In the PCN, breast screening coverage is 62.1% (England 69.9%) despite a three-year rise of +16.6% (England +8.4%). Cervical screening is 64.5% (England 66.8%), falling to 58.3% at Guildhall Street Surgery and 61.0% at The New Surgery. Lower screening uptake may delay early cancer detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data for East Kent Hospitals University NHS Foundation Trust, 70.0% of pathways met the 62-day cancer referral to treatment standard, 15.0 pp below the 85.0% standard (ICB 75.9%, England 71.2%). The 28-day faster diagnosis standard reached 71.3%, 3.7 pp below the 75.0% standard (England 79.3%). Combined 31-day treatment achieved 96.7% (96.0% standard). On provider waiting lists, 63.0% of patients waited 6+ weeks for non-obstetric ultrasound (England 19.6%) and 47.6% for MRI (England 21.4%).

    Pathways within standard (%)East KentEast Sussex HealthcareMaidstone and Tunbridge WellsKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2884.2081.7876.7879.32
    31-day treatment (96%)96.6798.1998.3595.8492.50
    62-day referral to treatment (85%)70.0167.0487.4375.9371.16
    Diagnostic waits over 6 weeks (%)East KentEast Sussex HealthcareMaidstone and Tunbridge WellsEngland
    MRI47.586.480.9221.40
    CT37.450.480.519.92
    Echocardiography14.1721.942.5728.48
    Colonoscopy9.580.7419.8030.83
    Gastroscopy22.160.3124.0329.02
    All 15 DM01 tests48.385.276.4223.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In provisional Community Services Dataset figures for Jun 2026, 65.8% of community contacts among Folkestone and Hythe residents were with adults aged 65+ (138,250 of 210,170 contacts). These figures describe wider borough resident activity rather than PCN-level delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practices achieve maximum clinical QOF points but show substantial variation in vaccination and immunisation

    In 2025/26, all four practices achieved 100.0% in the QOF clinical domain (England 97.1%). Vaccination and immunisation achievement trails England (55.2%), spanning 24.1 pp from 22.6% at Guildhall Street Surgery to 46.7% at Sandgate Road. Overall QOF achievement ranges from 90.3% at Guildhall Street Surgery to 94.0% at Sandgate Road (England 92.5%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Guildhall Street11465.734.6%70.7%74.1%
    Manor Clinic11842.043.9%68.8%69.0%
    Sandgate Road1073.224.7%72.7%56.9%
    The New Surgery8956.536.2%61.0%48.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNFolkestone and HytheAssetPCNFolkestone and Hythe
    Care homes (catchment)35 (677 beds)n/aSchools (catchment)55n/a
    Children's centres48Places of worship3478
    Libraries48Food banks (VCS)11
    Day centres (VCS)22Children and young people (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)921
    Primary academies915Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual reviews are 57.2% (England 65.7%; The New Surgery 46.5%) after falling 8.3% (-5.2 pp) over 2023 to 2025, an estimated scale of 1,155 unreviewed on the 2,697 register. For discussion: the PCN could run structured asthma recall using a single template, flexible slots and inhaler prescribing reviews. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Cardiovascular BP and lipid review

    On the 6,933 hypertension register (16.2%), under-80s BP control is 60.6% (England 67.8%; The New Surgery 55.0%), recent readings 83.5% (England 90.0%) and QRISK ≥ 20% lipid therapy 56.9% (England 63.6%). For discussion: the PCN could run pharmacist-led recall clinics to review uncontrolled hypertension and initiate lipid-lowering therapy. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    SMI physical health check outreach

    On the 681-patient SMI register (1.6% vs 1.0% in England; 48.2% of the borough register), annual BP checks are 78.5% (England 83.4%; The New Surgery 73.5%, Guildhall Street Surgery 77.0%). For discussion: the PCN could offer combined physical health check clinics, audit coding, and align outreach with system partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health review outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Cardiovascular BP and lipid review (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15